Investors
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is a venture capital that invests in therapeutic approaches and technologies
Recent Investments
- Asgard TherapeuticsSeries A(
41 ) - AignosticsSeries B( 52 )
- AignosticsSeries B( 52 )
- HepaRegeniXSeries C( 48 )
- Glox TherapeuticsSeed( 28 )
- Abalos TherapeuticsSeries A( 0 )
- Topas TherapeuticsSeries B( 34 )
- AignosticsSeries A( 52 )
- AignosticsSeries A( 52 )
- TacalyxSeed( 25 )
- TacalyxSeed( 25 )
- Cardior PharmaceuticalsSeries A( 0 )